Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020

BACKGROUND: This pilot study assesses the ability of plasma collected from Canadian blood donors in the first wave of the SARS‐CoV‐2 pandemic to neutralize later SARS‐CoV‐2 variants of concern (VOCs). STUDY DESIGN AND METHODS: A repeated cross‐sectional design was used, and a random cross‐sectional...

Descripción completa

Detalles Bibliográficos
Autores principales: Drews, Steven J., Abe, Kento T., Hu, Queenie, Samson, Reuben, Gingras, Anne‐Claude, Colwill, Karen, Rathod, Bhavisha, Wang, Jenny, Fazel‐Zarandi, Mahya, Yi, Qi‐Long, Robinson, Alyssia, Wood, Heidi, Tuite, Ashleigh, Fisman, David, Evans, David H., Lin, Yi‐Chan J., O'Brien, Sheila F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662190/
https://www.ncbi.nlm.nih.gov/pubmed/34662434
http://dx.doi.org/10.1111/trf.16713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662190/
https://www.ncbi.nlm.nih.gov/pubmed/34662434
http://dx.doi.org/10.1111/trf.16713

Ejemplares similares